[144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Rhea-AI Filing Summary

Recursion Pharmaceuticals, Inc. (RXRX) Form 144 filed reporting a proposed sale of 100,000 Class A shares through Fidelity Brokerage Services with an approximate aggregate market value of $476,000, with an approximate sale date of 09/25/2025 on NASDAQ. The filing states the shares were originally acquired as Founders Shares on 09/01/2016 and were issued as compensation. The notice also discloses prior sales by related parties during the past three months totaling 817,875 Class A shares for gross proceeds of $3,386,380.00. The signer represents no undisclosed material adverse information exists and includes the standard attestation language required under Rule 144.

Positive

• Disclosure compliance: The filer submitted a Form 144 specifying the proposed sale, broker, and sale date, satisfying Rule 144 notice requirements
• Transaction history provided: The filing lists prior related sales in the past three months, offering transparency on recent insider dispositions

Negative

• Significant insider liquidity: Related parties sold 817,875 Class A shares in the past three months for $3,386,380.00 in gross proceeds
• Planned sale size: Proposed sale of 100,000 Class A shares (aggregate market value $476,000) could add to insider supply in the market

Insights

Securities Analyst

TL;DR: Insider-related sales reported; current filing seeks to sell 100,000 Class A shares for roughly $476K.

The Form 144 documents an intended controlled securities disposition under Rule 144, indicating the seller acquired the shares as founders' compensation in 2016. The filing lists multiple recent disposals by the same family/affiliated entities totaling 817,875 shares in the prior three months with combined gross proceeds of $3,386,380.00. This is a disclosure of planned and recent insider liquidity rather than an operational or earnings event. Materiality for investors depends on share count relative to total outstanding shares and any potential market impact from continued insider sales.

Corporate Governance Expert

TL;DR: Form 144 compliance observed; filing includes standard attestation about material nonpublic information.

The document contains the required representations under Rule 144, including an attestation that the seller is not aware of undisclosed material adverse information. It identifies the nature of acquisition as founders' shares and states the transaction was compensation. The detailed listing of recent affiliated sales provides transparency about insider liquidity. The filing itself reflects routine compliance rather than new governance actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	100000	476000.00	427312960	09/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			100000	09/01/2016	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	500000	2640000.00
Gibson Family Trust 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	17875	94380.00
Lahwran-3 Llc 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	100000	528000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/26/2025	100000	484000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	09/10/2025	100000	471000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the RXRX Form 144 report?

The Form 144 reports a proposed sale of 100,000 Class A shares via Fidelity on approximately 09/25/2025 with an aggregate market value of $476,000.

Who originally acquired the shares being sold?

The shares were acquired as Founders Shares on 09/01/2016 and were recorded as compensation.

How many shares were sold by related parties in the past three months?

Related parties sold 817,875 Class A shares in the past three months for gross proceeds of $3,386,380.00.

Where will the proposed sale be executed?

The filing indicates the sale is to be executed on NASDAQ through Fidelity Brokerage Services LLC.

Does the filer assert possession of undisclosed material information?

No; the signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.